Your browser doesn't support javascript.
loading
Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
Oteri, Avuwa Joseph; Adamu, Usman; Dieng, Boubacar; Bawa, Samuel; Terna, Nomhwange; Nsubuga, Peter; Owoaje, Eme T; Kassogue, Modibo; Jean Baptiste, Anne Eudes; Braka, Fiona; Shuaib, Faisal.
Afiliação
  • Oteri AJ; National Primary Health Care Development Agency, Abuja, Nigeria. Electronic address: joseph.oteri@nphcda.gov.ng.
  • Adamu U; National Primary Health Care Development Agency, Abuja, Nigeria.
  • Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunisations, Nigeria.
  • Bawa S; World Health Organisation, Country Office, Abuja, Nigeria. Electronic address: bawasa@who.int.
  • Terna N; World Health Organisation, Country Office, Abuja, Nigeria. Electronic address: nomhwanget@who.int.
  • Nsubuga P; Global Public Health Solutions, Atlanta, GA, USA.
  • Owoaje ET; College of Medicine, University of Ibadan. Nigeria.
  • Kassogue M; United Nations Children's Fund, Country Office, Abuja, Nigeria.
  • Jean Baptiste AE; World Health Organisation, Country Office, Abuja, Nigeria.
  • Braka F; World Health Organisation, Country Office, Abuja, Nigeria.
  • Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria.
Vaccine ; 39 Suppl 3: C3-C11, 2021 11 17.
Article em En | MEDLINE | ID: mdl-33962837
BACKGROUND: The global polio eradication initiative has made giant stride by achieving a 99% reduction in Wild poliovirus (WPV) cases, with Nigeria on the verge of being declared polio-free following over 36 months without a WPV. The initiative has provided multiple resources, assets and lessons learnt that could be transitioned to other public health challenges, including improving the quality and vaccination coverage of measles campaigns in order to reduce the incidences of measles in Nigeria. We documented the polio legacy and assets used to support the national measles campaign in 2017/2018. METHODS: We documented the integration of the measles campaign coordination with the Polio Emergency Operation Centre (EOC) at national and state levels for planning and implementing the measles SIA. Specific polio strategies and assets, such as the EOC incident command framework and facilities, human resource surge capacity, polio GIS resource These strategies were adapted and adopted for the MVC implementation overcome challenges and improve vaccination coverage. We evaluated the performance through a set process and outcome indicators. RESULTS: All the 36 states and Federal Capital Territory used the structure and resources in Nigeria and provided counterpart financing for the MVC 2017/ 2018. The 11 polio high-risk states deployed the use of GIS for microplanning process, while daily call-in data were tracked in 99.7% of the LGAs and 70,846 reports were submitted real-time by supervisors using Open data kit (ODK). The national coverage achieved was 87.5% by the post-campaign survey with 65% of states reporting higher coverage in 2018 compared to 2015. CONCLUSION: Polio eradication assets and lessons learned can be applied to measles elimination efforts as the eradication and elimination efforts have similar strategies and programme implementation infrastructure needs. Leveraging these strategies and resources to support MVC planning and implementation resulted in more realistic planning, improved accountability and availability of human and fiscal resources. This approach may have resulted in better MVC outcomes and contributed to Nigeria's efforts in measles control and elimination.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliomielite / Sarampo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Poliomielite / Sarampo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article